Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents
Chiosis, G.; Caldas Lopes, E.; Solit, D.
Current Opinion in Investigational Drugs 7(6): 534-541
2006
ISSN/ISBN: 1472-4472 PMID: 16784024 Document Number: 596837
Heat shock protein (Hsp)90 is a chaperone with essential roles in maintaining transformation and in elevating the survival and growth potential of cancer cells. The recognition of Hsp90 as an important target in cancer therapy has prompted the identification, development and clinical translation of a large array of Hsp90 inhibitors. This review discusses the modalities that may interfere with this chaperone's function and describes the status of existing and emerging Hsp90 inhibitor classes.